CSD1805: Study to Assess Nicotine Uptake and Product Use Behavior in Moist Snuff Consumers Using Two Moist Snuff Products
NCT03688776 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2020-09-25
Summary
The purpose of this study is to compare nicotine uptake and product use behavior during and following use of two moist snuff products in generally healthy, adult moist snuff users.
Conditions
- Tobacco Use
Interventions
- OTHER
-
1805AA
A moist snuff product
- OTHER
-
1805AB
A moist snuff product
Sponsors & Collaborators
-
ICON Clinical Research Limited
collaborator UNKNOWN -
RAI Services Company
lead INDUSTRY
Principal Investigators
-
Emanuel DeNoia, MD · ICON Clinical Research
-
Melanie Fein, MD · High Point Clinical Trial Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-10-19
- Primary Completion
- 2018-12-02
- Completion
- 2018-12-02
Countries
- United States
Study Locations
More Related Trials
-
CSD231005 Nicotine Pouch Biomarkers of Exposure
NCT06303115 ·Status: COMPLETED ·Phase: NA
-
CSD201001: Study to Assess Elements of Abuse Liability for Three Nicotine Pouches
NCT05129657 ·Status: COMPLETED ·Phase: NA
-
CSD1603: A Crossover Study to Evaluate the Exposure to "Tar" and Nicotine From 100s Menthol Cigarette Products
NCT03063047 ·Status: COMPLETED ·Phase: NA
-
CSD201002: Study to Assess Nicotine Uptake From P10 Nicotine Pouches
NCT05081154 ·Status: COMPLETED ·Phase: NA
-
CSD190401: A Study to Assess Elements of Abuse Liability for Nicotine-containing Pouch Tobacco Products
NCT04372290 ·Status: COMPLETED ·Phase: NA
-
CSD190301: A Study to Assess Elements of Abuse Liability for Two Dissolvable Nicotine Lozenge Tobacco Products
NCT04167384 ·Status: COMPLETED ·Phase: NA
-
CSD170301: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Four Different Electronic Cigarettes
NCT03105804 ·Status: COMPLETED ·Phase: NA
-
CSD170304: Study to Assess Nicotine Uptake in Smokers From Electronic and Combustible Cigarettes
NCT03294356 ·Status: COMPLETED ·Phase: NA
-
CSD190601: A Study to Determine Subject Puffing Patterns of Electronic Nicotine Delivery Systems in an Ambulatory Setting
NCT04308434 ·Status: COMPLETED ·Phase: NA
-
CSD190202: Study to Assess Elements of Abuse Liability for Two Electronic Nicotine Delivery Systems
NCT04094363 ·Status: COMPLETED ·Phase: NA
-
CSD201004: An Actual Use Study of P10 and P13 Nicotine Pouches Among U.S. Adult Smokers
NCT05184920 ·Status: COMPLETED
-
CSD190203: A Study to Determine Subject Puffing Patterns of an Electronic Nicotine Delivery System in an Ambulatory Setting
NCT04104152 ·Status: COMPLETED ·Phase: NA
-
CSD201301: Study to Assess Elements of Abuse Liability for Four P13 Nicotine Pouches
NCT05294497 ·Status: COMPLETED ·Phase: NA
-
Nicotine Pharmacokinetics and Subjective Effects of Oral Nicotine Products Relative to Smokeless Tobacco in Adult Users
NCT06691386 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)
NCT00109135 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Characterize Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouches in Adult Cigarette Smokers
NCT04846088 ·Status: COMPLETED ·Phase: NA
-
CSD210202: A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery Systems
NCT04751461 ·Status: COMPLETED ·Phase: NA
-
A Randomised, Cross-over, Relative Bioavailability Study of Nicotine Delivery and Nicotine Extraction From Oral Products
NCT04891406 ·Status: COMPLETED ·Phase: NA
-
CSD170303: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes
NCT03234010 ·Status: COMPLETED ·Phase: NA
-
CSD170302: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes
NCT03233997 ·Status: COMPLETED ·Phase: NA
-
CSD201201: Study to Assess Elements of Abuse Liability for Electronic Nicotine Delivery System P12
NCT05210699 ·Status: COMPLETED ·Phase: NA
-
Assessment of V0018 2.5 mg Effect on Craving
NCT02357888 ·Status: COMPLETED ·Phase: PHASE2
-
Controlled Study of the Ability of a Smokefree Tobacco Product to Increase the Quit Rate Among Cigarette Smokers
NCT00843622 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5 mg/Day or 20 mg/Day, Versus Placebo, as an Aid to Smoking Cessation (STRATUS US)
NCT00358228 ·Status: COMPLETED ·Phase: PHASE3
-
CSD170401: Study to Assess Elements of Abuse Liability for Three Electronic Tobacco Vapor Products During an 11-Day In-Clinic Confinement
NCT03126357 ·Status: COMPLETED ·Phase: NA